Early Recurrence in Completely Resected IIIB and IIIC Melanoma Warrants Restaging Prior to Adjuvant Therapy-Reference-Cited by-同舟云学术

Early Recurrence in Completely Resected IIIB and IIIC Melanoma Warrants Restaging Prior to Adjuvant Therapy

Published:2019-03-04 Issue:12 Volume:26 Page:3945-3952
ISSN:1068-9265
Container-title:Annals of Surgical Oncology
language:en
Short-container-title:Ann Surg Oncol

Author:

Bloemendal Martine,van Willigen Wouter W.,Bol Kalijn F.,Boers-Sonderen Marye J.,Bonenkamp Johannes J.,Werner J. E. M.,Aarntzen Erik H. J. G.,Koornstra Rutger H. T.,de Groot Jan Willem B.,de Vries I. Jolanda M.,van der Hoeven Jacobus J. M.,Gerritsen Winald R.,de Wilt Johannes H. W.

Funder

Nederlandse Organisatie voor Wetenschappelijk Onderzoek

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Surgery

Link

http://link.springer.com/content/pdf/10.1245/s10434-019-07274-2.pdf

Reference34 articles.

1. Romano E, Scordo M, Dusza SW, Coit DG, Chapman PB. Site and timing of first relapse in stage III melanoma patients: implications for follow-up guidelines. J Clin Oncol. 2010;28(18):3042–47.

2. Balch CM, Gershenwald JE, Soong S-J, et al. Final version of 2009 AJCC melanoma staging and classification. J Clin Oncol. 2009;27(36):6199–06.

3. van Akkooi AC, Bouwhuis MG, van Geel AN, et al. Morbidity and prognosis after therapeutic lymph node dissections for malignant melanoma. Eur J Surg Oncol. 2007;33(1):102–08.